Marcos Cerqueira Selected Research

Marcos Cerqueira Research Topics

4	Rheumatoid Arthritis 07/2017 - 01/2016
3	Rheumatic Diseases (Rheumatism) 10/2022 - 01/2017
3	Psoriatic Arthritis 04/2020 - 07/2015
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2022
1	Surgical Wound Infection 10/2022
1	Adult-Onset Still's Disease 12/2021
1	Sacroiliitis 07/2021
1	Osteoarthritis 07/2020
1	Pain (Aches) 07/2020
1	Hepatitis 04/2020
1	Vascular Skin Diseases 04/2020
1	Axial Spondyloarthritis 07/2017
1	Ankylosing Spondylitis 07/2017
1	Infections 04/2017
1	Hepatitis B 04/2017
1	Tuberculosis (Tuberculoses) 04/2017
1	Hematologic Neoplasms (Hematological Malignancy) 04/2017
1	Necrosis 01/2017
1	Arthritis (Polyarthritis) 01/2016

3	Antirheumatic Agents (DMARD)IBA 10/2022 - 04/2017
1	Azathioprine (Imuran)FDA LinkGeneric 10/2022
1	Immunologic Factors (Immunomodulators)IBA 10/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 10/2022
1	Prednisone (Sone)FDA LinkGeneric 10/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2022
1	GlucocorticoidsIBA 10/2022
1	tocilizumab (atlizumab)FDA Link 12/2021
1	C-Reactive ProteinIBA 07/2021
1	4-hexyloxyaniline (HOA)IBA 07/2020
1	Infliximab (Remicade)FDA Link 04/2020
1	phenyl-2-aminoethyl sulfide (PAES)IBA 04/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2020
1	Methotrexate (Mexate)FDA LinkGeneric 04/2017
1	ametantrone (HAQ)IBA 01/2017
1	Tumor Necrosis Factor InhibitorsIBA 01/2017
1	Rheumatoid FactorIBA 01/2016

3	Biological Therapy 07/2017 - 07/2015
1	Therapeutics 04/2017